Get 20% lifetime commission for referring investors to digrin.com
here.
Surrozen, Inc. ( SRZN) - Key Metrics
SRZN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.43 | $4.30 | -$0.64 | -$0.64 |
| 2026Q1 | $0.46 | -$11.65 | -$1.14 | -$1.15 |
| 2025Q4 | $0.06 | -$20.13 | -$0.64 | -$0.65 |
| 2025Q3 | $0.11 | -$8.36 | -$1.05 | -$1.06 |
| 2025Q2 | $0.12 | $4.65 | -$0.72 | -$0.72 |
SRZN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 2.36 |
| 2026Q1 | 0% | -0.63 |
| 2025Q4 | 0% | -0.24 |
| 2025Q3 | 0% | -0.39 |
| 2025Q2 | 0% | 0.88 |
SRZN
Price: $23.44
52 week price:
Earnings Per Share: -38.60 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 41336
Market Capitalization: 219.2 million